These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Early anticoagulation after aortic valve replacement with bioprostheses: time to abandon it? di Marco F; Meneghetti G; Gerosa G J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1482-3. PubMed ID: 16256819 [No Abstract] [Full Text] [Related]
28. Images in cardiovascular medicine. Percutaneous aortic valve replacement in animals. Boudjemline Y; Bonhoeffer P Circulation; 2004 Mar; 109(10):e161. PubMed ID: 15023897 [No Abstract] [Full Text] [Related]
29. Percutaneous implantation of CoreValve aortic prostheses in patients with a mechanical mitral valve. Bruschi G; De Marco F; Oreglia J; Colombo P; Fratto P; Lullo F; Paino R; Frigerio M; Martinelli L; Klugmann S Ann Thorac Surg; 2009 Nov; 88(5):e50-2. PubMed ID: 19853076 [TBL] [Abstract][Full Text] [Related]
30. [Echocardiographic evaluation of the effect after BN-mode heterograft valve replacement (author's transl)]. Liu HY Zhonghua Wai Ke Za Zhi; 1981 Oct; 19(10):586-9. PubMed ID: 7341120 [No Abstract] [Full Text] [Related]
31. Which valve and which size should we use in the valve-on-valve technique for re-do mitral valve surgery? Shibata T; Inoue K; Ikuta T; Bito Y; Yoshioka Y; Mizoguchi H Interact Cardiovasc Thorac Surg; 2009 Feb; 8(2):206-10. PubMed ID: 19010939 [TBL] [Abstract][Full Text] [Related]
32. Bioprostheses in tricuspid and mitral valve positions for 100 months with heavier calcific deposits on the left-sided valve followed by new bioprostheses in both positions for 95 months with heavier calcific deposits on the right-sided valve. Potkin BN; McIntosh CL; Cannon RO; Roberts WC Am J Cardiol; 1988 Apr; 61(11):947-9. PubMed ID: 3354478 [No Abstract] [Full Text] [Related]
33. Prognosis in valve replacement. Scully HE Trans Assoc Life Insur Med Dir Am; 1987; 70():129-34. PubMed ID: 3603933 [No Abstract] [Full Text] [Related]
34. A preliminary report on low-profile and pericardial bioprostheses: a new combination in particular anatomical situations. Gagliardi C; Musumeci A; Golino A; Del Naja C; Stassano P; Iorio D; Spampinato N Life Support Syst; 1985; 3(4):357-63. PubMed ID: 4068757 [TBL] [Abstract][Full Text] [Related]
35. Factors influencing calcification of cardiac bioprostheses in adolescent sheep. Flameng W; Meuris B; Yperman J; De Visscher G; Herijgers P; Verbeken E J Thorac Cardiovasc Surg; 2006 Jul; 132(1):89-98. PubMed ID: 16798307 [TBL] [Abstract][Full Text] [Related]
37. The success of clopidogrel treatment for recurrent coronary thrombosis in a patient with aortic and mitral valve replacement. Kaya MG; Durakoglugil E; Yalcin R Clin Appl Thromb Hemost; 2008 Oct; 14(4):492-3. PubMed ID: 18160612 [No Abstract] [Full Text] [Related]
38. A normofunctioning caged-ball aortic valve prosthesis for 31 years. Başkurt M; Turhan FN; Okçün B; Küçükoğlu S Anadolu Kardiyol Derg; 2009 Jun; 9(3):255-6. PubMed ID: 19520665 [No Abstract] [Full Text] [Related]
39. Spontaneous disruption of bovine pericardial prosthesis--clinical management and histopathologic changes. Li SQ; Hua M; Cao KH; Niu YM Chin Med J (Engl); 1985 Dec; 98(12):887-8. PubMed ID: 3938722 [No Abstract] [Full Text] [Related]
40. [Enlargement of the aortic root with a bovine pericardial patch preserved in glutaraldehyde]. Braile DM; Bilaqui A; Ardito RV; Angeloni MA; Garzon SA; Greco OT; Jacob JL; Nicolau JC; Ayoub JC; Sardilli MH Arq Bras Cardiol; 1983 Oct; 41(4):289-96. PubMed ID: 6675624 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]